New research from the Sackler Institute for Developmental Psychobiology at Columbia University Medical Center (CUMC) identifies a potential biomarker that
predicts atypical development in 1 - to 2 - month - old infants at high versus low familial risk for developing autism spectrum disorders (ASD).